Cargando…

Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions

BACKGROUND: Irradiation with ultra-high dose rate (FLASH) has been shown to spare normal tissue without hampering tumor control in several in vivo studies. Few cell lines have been investigated in vitro, and previous results are inconsistent. Assuming that oxygen depletion accounts for the FLASH spa...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrian, Gabriel, Konradsson, Elise, Beyer, Sarah, Wittrup, Anders, Butterworth, Karl T., McMahon, Stephen J., Ghita, Mihaela, Petersson, Kristoffer, Ceberg, Crister
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358772/
https://www.ncbi.nlm.nih.gov/pubmed/34395253
http://dx.doi.org/10.3389/fonc.2021.686142
_version_ 1783737411963977728
author Adrian, Gabriel
Konradsson, Elise
Beyer, Sarah
Wittrup, Anders
Butterworth, Karl T.
McMahon, Stephen J.
Ghita, Mihaela
Petersson, Kristoffer
Ceberg, Crister
author_facet Adrian, Gabriel
Konradsson, Elise
Beyer, Sarah
Wittrup, Anders
Butterworth, Karl T.
McMahon, Stephen J.
Ghita, Mihaela
Petersson, Kristoffer
Ceberg, Crister
author_sort Adrian, Gabriel
collection PubMed
description BACKGROUND: Irradiation with ultra-high dose rate (FLASH) has been shown to spare normal tissue without hampering tumor control in several in vivo studies. Few cell lines have been investigated in vitro, and previous results are inconsistent. Assuming that oxygen depletion accounts for the FLASH sparing effect, no sparing should appear for cells irradiated with low doses in normoxia. METHODS: Seven cancer cell lines (MDA-MB-231, MCF7, WiDr, LU-HNSCC4, HeLa [early passage and subclone]) and normal lung fibroblasts (MRC-5) were irradiated with doses ranging from 0 to 12 Gy using FLASH (≥800 Gy/s) or conventional dose rates (CONV, 14 Gy/min), with a 10 MeV electron beam from a clinical linear accelerator. Surviving fraction (SF) was determined with clonogenic assays. Three cell lines were further studied for radiation-induced DNA-damage foci using a 53BP1-marker and for cell cycle synchronization after irradiation. RESULTS: A tendency of increased survival following FLASH compared with CONV was suggested for all cell lines, with significant differences for 4/7 cell lines. The magnitude of the FLASH-sparing expressed as a dose-modifying factor at SF=0.1 was around 1.1 for 6/7 cell lines and around 1.3 for the HeLa(subclone). Similar cell cycle distributions and 53BP1-foci numbers were found comparing FLASH to CONV. CONCLUSION: We have found a FLASH effect appearing at low doses under normoxic conditions for several cell lines in vitro. The magnitude of the FLASH effect differed between the cell lines, suggesting inherited biological susceptibilities for FLASH irradiation.
format Online
Article
Text
id pubmed-8358772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83587722021-08-13 Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions Adrian, Gabriel Konradsson, Elise Beyer, Sarah Wittrup, Anders Butterworth, Karl T. McMahon, Stephen J. Ghita, Mihaela Petersson, Kristoffer Ceberg, Crister Front Oncol Oncology BACKGROUND: Irradiation with ultra-high dose rate (FLASH) has been shown to spare normal tissue without hampering tumor control in several in vivo studies. Few cell lines have been investigated in vitro, and previous results are inconsistent. Assuming that oxygen depletion accounts for the FLASH sparing effect, no sparing should appear for cells irradiated with low doses in normoxia. METHODS: Seven cancer cell lines (MDA-MB-231, MCF7, WiDr, LU-HNSCC4, HeLa [early passage and subclone]) and normal lung fibroblasts (MRC-5) were irradiated with doses ranging from 0 to 12 Gy using FLASH (≥800 Gy/s) or conventional dose rates (CONV, 14 Gy/min), with a 10 MeV electron beam from a clinical linear accelerator. Surviving fraction (SF) was determined with clonogenic assays. Three cell lines were further studied for radiation-induced DNA-damage foci using a 53BP1-marker and for cell cycle synchronization after irradiation. RESULTS: A tendency of increased survival following FLASH compared with CONV was suggested for all cell lines, with significant differences for 4/7 cell lines. The magnitude of the FLASH-sparing expressed as a dose-modifying factor at SF=0.1 was around 1.1 for 6/7 cell lines and around 1.3 for the HeLa(subclone). Similar cell cycle distributions and 53BP1-foci numbers were found comparing FLASH to CONV. CONCLUSION: We have found a FLASH effect appearing at low doses under normoxic conditions for several cell lines in vitro. The magnitude of the FLASH effect differed between the cell lines, suggesting inherited biological susceptibilities for FLASH irradiation. Frontiers Media S.A. 2021-07-29 /pmc/articles/PMC8358772/ /pubmed/34395253 http://dx.doi.org/10.3389/fonc.2021.686142 Text en Copyright © 2021 Adrian, Konradsson, Beyer, Wittrup, Butterworth, McMahon, Ghita, Petersson and Ceberg https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Adrian, Gabriel
Konradsson, Elise
Beyer, Sarah
Wittrup, Anders
Butterworth, Karl T.
McMahon, Stephen J.
Ghita, Mihaela
Petersson, Kristoffer
Ceberg, Crister
Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title_full Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title_fullStr Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title_full_unstemmed Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title_short Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
title_sort cancer cells can exhibit a sparing flash effect at low doses under normoxic in vitro-conditions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358772/
https://www.ncbi.nlm.nih.gov/pubmed/34395253
http://dx.doi.org/10.3389/fonc.2021.686142
work_keys_str_mv AT adriangabriel cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT konradssonelise cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT beyersarah cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT wittrupanders cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT butterworthkarlt cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT mcmahonstephenj cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT ghitamihaela cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT peterssonkristoffer cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions
AT cebergcrister cancercellscanexhibitasparingflasheffectatlowdosesundernormoxicinvitroconditions